Alexander Maxwell
Value, growth, long-term horizon, biotech

Anacor Pharmaceuticals: A Small Cap With Tremendous Upside And Multiple Short To Mid Term Catalysts

Anacor Pharmaceuticals (NASDAQ:ANAC) is a developmental stage pharmaceutical company with multiple near and long term catalysts. These catalysts have the potential to drive company growth and shareholder value for many years in the future. The catalysts have the potential to create huge upside for investors who are willing to hold onto the stock long term.


The catalysts regarding Tavaborole can be summarized in the following table:

Catalysts Regarding Tavaborole
Catalyst Approximate Date
NDA Filing Mid-2013
PDUFA Mid-2014 (depending on NDA classification)
Commercialization Decision Latter part of 2013

The first major catalyst is the filing of a New Drug Application (NDA) for Tavaborole, for the treatment of Onychomycosis. Onychomycosis is a rather common condition (a fungal infection of...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details